RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer

被引：0
|
作者：
Yueyue Yang
Jiafei Lin
Susu Guo
Xiangfei Xue
Yikun Wang
Shiyu Qiu
Jiangtao Cui
Lifang Ma
Xiao Zhang
Jiayi Wang
机构：
[1] Shanghai Tenth People’s Hospital of Tongji University,Department of Clinical Laboratory
[2] Ruijin Hospital,Department of Clinical Laboratory
[3] Shanghai Jiao Tong University School of Medicine,Shanghai Institute of Thoracic Oncology
[4] Shanghai Chest Hospital,Department of Thoracic Surgery
[5] Shanghai Jiao Tong University,undefined
[6] Shanghai Institute of Thoracic Tumors,undefined
[7] Shanghai Chest Hospital,undefined
[8] Shanghai Jiao Tong University,undefined
来源：
Cancer Cell International | / 20卷
关键词：
GSS; Proteasome; Diagnosis; Phosphorylation; Glutathione; Erastin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Response to FOLFOX chemotherapy in patients with colorectal cancer according to RRM2 expression
    Yan, Chongxian
    Fang, Zejun
    Liu, Hong
    Shao, Jianli
    Wang, Anhua
    Sun, Long
    Zhu, Zhihua
    Luo, Shuchai
    Chen, Xiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 21970 - 21978
  • [22] RRM2 Is a Putative Biomarker and Promotes Bladder Cancer Progression via PI3K/AKT/mTOR Pathway
    Guo, Linfa
    Zhao, Yiqiao
    Bai, Xiaojie
    Wang, Xiaolong
    Tuoheti, Kuerban
    Cao, Yuanfei
    Zuo, Yingtong
    Zhang, Xinhua
    Liu, Tongzu
    JOURNAL OF CELLULAR PHYSIOLOGY, 2025, 240 (01)
  • [23] Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer
    Tang, Qiuying
    Wu, Lingyun
    Xu, Mengyou
    Yan, Danfang
    Shao, Jimin
    Yan, Senxiang
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (05): : 1368 - 1379
  • [24] Bioinformatics analysis revealing prognostic significance of RRM2 gene in breast cancer
    Chen, Wei-xian
    Yang, Liang-gen
    Xu, Ling-yun
    Cheng, Lin
    Qian, Qi
    Sun, Li
    Zhu, Yu-lan
    BIOSCIENCE REPORTS, 2019, 39
  • [25] Targeting RRM2 in 3D Tumor Organoid Models of High Risk Hepatoblastoma
    Zhu, L.
    Li, L.
    Qian, M.
    Hamel, L.
    Lopez-Terrada, D.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S370 - S370
  • [26] siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
    Zheng, Shuquan
    Wang, Xiaoxia
    Weng, Yu-Hua
    Jin, Xingyu
    Ji, Jia-Li
    Guo, Liangxia
    Hu, Bo
    Liu, Nan
    Cheng, Qiang
    Zhang, Jianqi
    Bai, Huicheng
    Yang, Tongren
    Xia, Xin-Hua
    Zhang, Hong-Yan
    Gao, Shan
    Huang, Yuanyu
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 12 : 805 - 816
  • [27] Targeting RRM2 in 3D Tumor Organoid Models of High Risk Hepatoblastoma
    Zhu, L.
    Li, L.
    Qian, M.
    Hamel, L.
    Lopez-Terrada, D.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S92 - S92
  • [28] RRM2 Is a CTNNB1 Transport Regulator Promoting Colon Cancer Progression
    Moon, Sung Ung
    Lee, Jong Hyeon
    Shah, Masaud
    Yoon, Sukjoon
    Woo, Hyun Goo
    ANTICANCER RESEARCH, 2024, 44 (06) : 2471 - 2485
  • [29] High RRM2 expression has poor prognosis in specific types of breast cancer
    Shi, Shen-chao
    Zhang, Yi
    Wang, Tao
    PLOS ONE, 2022, 17 (03):
  • [30] Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth
    Rahman, Mohammad Aminur
    Amin, A. R. M. Ruhul
    Wang, Xu
    Zuckerman, Jonathan E.
    Choi, Chung Hang J.
    Zhou, Bingsen
    Wang, Dongsheng
    Nannapaneni, Sreenivas
    Koenig, Lydia
    Chen, Zhengjia
    Chen, Zhuo
    Yen, Yun
    Davis, Mark E.
    Shin, Dong M.
    JOURNAL OF CONTROLLED RELEASE, 2012, 159 (03) : 384 - 392
12345